SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Volcano Corporation
(NASDAQ: VOLC), a leading developer and manufacturer of precision
guided therapy tools designed to enhance the diagnosis and
treatment of coronary and peripheral vascular disease, said today
that it will be participating in the Canaccord Genuity 2013 Medical
Technology & Diagnostics Forum on Thursday, November 14.
The presentation by John
Dahldorf, chief financial officer, will begin at
10:30 a.m., Eastern Standard Time
(7:30 a.m., Pacific Standard Time).
The presentation will be available through
http://wsw.com/webcast/canaccord12/ and via the company's website
at www.volcanocorp.com.
Volcano Corporation is revolutionizing the medical device
industry with a broad suite of technologies that make imaging and
therapy simpler, more informative and less invasive. Our products
empower physicians around the world with a new generation of
analytical tools that deliver more meaningful information—using
light and sound as the guiding elements. Founded in cardiovascular
care and expanding into other specialties, Volcano is changing the
assumption about what is possible in improving patient outcomes by
combining imaging and therapy together. For more information, visit
the company's website at www.volcanocorp.com.
SOURCE Volcano Corporation